# Canadian Humira Post Marketing Observational Epidemiological Study Assessing Effectiveness in Psoriatic Arthritis

> **NCT01559038** · — · COMPLETED · sponsor: **AbbVie (prior sponsor, Abbott)** · enrollment: 483 (actual)

## Conditions studied

- Psoriatic Arthritis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01559038
- **Lead sponsor:** AbbVie (prior sponsor, Abbott)
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02-16
- **Primary completion:** 2019-11-19
- **Final completion:** 2019-11-19
- **Target enrollment:** 483 (ACTUAL)
- **Last updated:** 2020-11-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01559038

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01559038, "Canadian Humira Post Marketing Observational Epidemiological Study Assessing Effectiveness in Psoriatic Arthritis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01559038. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*